Equillium (EQ) Receivables - Other (2022 - 2025)

Equillium (EQ) reported Receivables - Other of $108000.0 for Q4 2025, down 39.33% year-over-year from $178000.0 in Q4 2024, and down 12.2% quarter-over-quarter from $123000.0 in Q3 2025.

Equillium (EQ) Receivables - Other (2022 - 2025) Analysis & Trends

Equillium (EQ) has 4 years of Receivables - Other data on file, last reported at $108000.0 in Q4 2025.

  • Receivables - Other for Q4 2025 came in at $108000.0, down 39.33% year-over-year; the trailing twelve-month figure through Dec 2025 was $108000.0 (down 39.33% YoY), and the FY2025 annual result was $108000.0, down 39.33% from the prior year.
  • Receivables - Other retreated to $108000.0 in Q4 2025 per EQ's latest filing, from $123000.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $497000.0 in Q4 2023 and troughed at $35000.0 in Q2 2025.
  • A 4-year average of $245200.0 and a median of $223500.0 in 2022 frame the typical range for Receivables - Other.
  • The sharpest annual moves came in 2023 and 2025: Receivables - Other soared 84.76% in 2023, then sank 91.4% in 2025.
  • A 4-year view of Receivables - Other shows it stood at $269000.0 in 2022, then soared by 84.76% to $497000.0 in 2023, then sank by 64.19% to $178000.0 in 2024, then tumbled by 39.33% to $108000.0 in 2025.
  • Business Quant data shows EQ's Receivables - Other at $108000.0 in Q4 2025, $123000.0 in Q3 2025, and $35000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Equillium 293.17 Mn 232.78 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 108,000.00
Dec 31, 2025 108,000.00
Sep 30, 2025 123,000.00
Sep 30, 2025 123,000.00
Jun 30, 2025 35,000.00
Jun 30, 2025 35,000.00
Mar 31, 2025 73,000.00
Mar 31, 2025 73,000.00
Dec 31, 2024 178,000.00
Dec 31, 2024 178,000.00
Sep 30, 2024 275,000.00
Sep 30, 2024 275,000.00
Jun 30, 2024 407,000.00
Jun 30, 2024 407,000.00
Mar 31, 2024 487,000.00
Mar 31, 2024 487,000.00
Dec 31, 2023 497,000.00
Dec 31, 2023 497,000.00
Dec 31, 2022 269,000.00
Dec 31, 2022 269,000.00